CAMP
Camp4 Therapeutics
$3.42
+$0.26 (+8.23%)Jul 27, 2026
Key metrics
The numbers that frame CAMP today
- Market cap
- $177.59M
- P/E (TTM)
- -2.1
- EV / FCF
- -3.0
- Gross margin
- 100%
- EV / Sales
- 20.3
- ROIC
- -12,049%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.32
- 52wk High
- $7.75
Growth
Revenue and earnings trend for CAMP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CAMP
Is Camp4 Therapeutics a good buy?
Hold. Camp4 Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Camp4 Therapeutics is selling at a very high price.
What is the market capitalization of CAMP?
Camp4 Therapeutics's market capitalization is $177.59M.
What is the P/E ratio for CAMP stock?
Camp4 Therapeutics's current P/E ratio is -2.1.
What is the 52-week high for CAMP stock?
The 52-week high for Camp4 Therapeutics is $7.75. The current close of $3.42 is 55.9% below that high.
What is the 52-week low for CAMP stock?
The 52-week low for Camp4 Therapeutics is $1.32. The current close of $3.42 is 159.1% above that low.
Does CAMP stock pay dividends?
Camp4 Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CAMP?
Camp4 Therapeutics's Debt / Equity ratio is 0.07.